Schizophrenia: a multisystem disease?
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
A multisystem disease is one that usually affects a number of organs and tissues during the course of the illness (Dorland, 2008). It has long been observed that some individuals with schizophrenia have levels of general physical illnesses in excess of that seen in the general population, but recent studies suggest that most people with schizophrenia have co-morbid physical disease and multiple related risk factors. Jones et al. (2004) reported that 74% of patients with schizophrenia had at least one chronic co-morbid medical condition. Bell et al. (2009) found that 90% of Medicaid recipients with schizophrenia had at least one major metabolic risk factor. Using a higher standard of at least three major risk factors (NCEP-ATP-III guidelines: abdominal obesity, hypertriglyceridemia, dyslipidemia, hypertension and hyperglycemia) approximately 40% of European patients and up to 51.6% patients with schizophrenia in the United States satisfy criteria for the metabolic syndrome (De Hert et al., 2009; Meyer et al., 2005). In the METEOR study, the largest analysis of risk factors in schizophrenia and related disorders reported that 69.9% had lipid disorders and 43.4% had hypertension (De Hert et al., 2008). Together this evidence suggests that most people with schizophrenia have a significant co-morbid physical illness and further the great majority have metabolic risk factors (Mitchell and Malone, 2006). Rates of co-morbidity appear to be influenced by the severity of psychiatric symptoms, the setting of study and nature of prescribed medication. Physical co-morbidity in turn has an impact upon quality of life, suicide attempts and mortality, even when suicide is eliminated (Heila et al., 2005; Hennekens et al., 2005; Joukamaa et al., 2006; Kolotkin et al., 2008). While core symptoms of schizophrenia usually first emerge in the late teens and early twenties, peripheral physical disease gradually increases with age (Bresee et al., 2010). Similarly metabolic risk factors are usually elevated at first episode but accumulate with time (Saddichha et al., 2008). Lifestyle and cardiovascular risk factors play an important role in the physical complications but they do not appear to account for the entire variance (Connolly and Kelly, 2005). Antipsychotic drugs certainly contribute to physical co-morbidity (Oriot et al., 2008), but this effect is likely to be magnified in a vulnerable population. All metabolic risk factors are important but we should give special attention to those that are potentially reversible. Recent research has highlighted some valuable insights in the following areas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolic syndrome in people with schizophrenia: a review
DE HERT, M., SCHREURS, V., VANCAMPFORT, D., & VAN WINKEL, R. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00199.x · Cited by 634 · cited 2×
“Approximately 50% of those with schizophrenia are overweight judging by waist circumference (De Hert et al., 2009) and this figure may be around 20% in first episode patients (De Hert et al., 2006).”
BackgroundInfluentialSchizophrenia, neuroleptic medication and mortality
Joukamaa, M., Heliövaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.2.122 · Cited by 395 · cited 1×
“Physical co-morbidity in turn has an impact upon quality of life, suicide attempts and mortality, even when suicide is eliminated (Heila et al., 2005; Hennekens et al., 2005; Joukamaa et al., 2006; Kolotkin et al., 2008).”
Background
Cited by
Savignac, H. M., Couch, Y., Stratford, M., Bannerman, D. M., Tzortzis, G., Anthony, D. C., & Burnet, P. W. J. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.10.007 · Cited by 223
“…immune function has been associated with several neuropsychiatric disorders that are linked to altered glutamate and 5-HT neurotransmission (Mitchell and Dinan, 2010; Marsden, 2011; Dantzer, 2012), the ability to use prebiotics to modify neural function by manipulating the gut microbiota,…”
Diabetes mellitus and severe mental illness: mechanisms and clinical implications
Holt, R. I. G., & Mitchell, A. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.203 · Cited by 179
Self-citationNeurobiological effects of physical exercise in schizophrenia: a systematic review.
Vancampfort, D., Probst, M., De Hert, M., Soundy, A., Stubbs, B., Stroobants, M., & De Herdt, A. (2014) · Disability and Rehabilitation · doi:10.3109/09638288.2013.874505 · Cited by 80
Beary, M., Hodgson, R., & Wildgust, H. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112440512 · Cited by 79
“Historically, schizophrenia was viewed only as a mental disorder; however, there is now sufficient evidence to support the view that it is a multisystem disease (Mitchell and Dinan, 2010).”
BackgroundBajor, L. A., Gunzler, D., Einstadter, D., Thomas, C., McCormick, R., Perzynski, A. T., Kanuch, S. W., Cassidy, K. A., Dawson, N. V., & Sajatovic, M. (2015) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217415589307 · Cited by 30
Metadata
- Authors
- Mitchell, A. J., & Dinan, T. G.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2010-10-05
- Volume
- 24
- Issue
- 4_suppl
- Pages
- 5-7
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2012306745
- Cited by
- 24
- References
- 2
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Schizophrenia: a multisystem disease? https://app.cochat.ai/papers/10.1177/1359786810382059
- The paper
- Mitchell, A. J., & Dinan, T. G. (2010). Schizophrenia: a multisystem disease? Journal of Psychopharmacology. https://doi.org/10.1177/1359786810382059
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.